Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Pharmaceutical Statistics
|
February 24, 2017
Probability of success for phase III after exploratory biomarker analysis in phase II
Heiko Götte, Marietta Kirchner, Martin Oliver Sailer
CPT: Pharmacometrics & Systems Pharmacology
|
August 30, 2023
Pharmacometrics enhanced Bayesian borrowing approach to improve clinical trial efficiency: Case of empagliflozin in type 2 diabetes
Lucie Fayette, Martin Oliver Sailer, Alejandro Perez-Pitarch
Pharmaceutical Statistics
|
May 20, 2021
The detailed clinical objectives approach to designing clinical trials and choosing estimands
James Bell, Alan Hamilton, Oliver Sailer, et al.
Statistics in Medicine
|
April 25, 2017
Simulation-based adjustment after exploratory biomarker subgroup selection in phase II
Heiko Götte, Marietta Kirchner, Martin Oliver Sailer, et al.
Statistical Methods in Medical Research
|
April 16, 2026
Bayesian sample size determination using robust commensurate priors with interpretable discrepancy weights
Lou E Whitehead, James Ms Wason, Oliver Sailer, et al.
Biometrics
|
April 29, 2016
On confidence intervals for the hazard ratio in randomized clinical trials
Dan-Yu Lin, Luyan Dai, Gang Cheng, et al.
Journal of Biopharmaceutical Statistics
|
March 8, 2023
Propensity score stratified MAP prior and posterior inference for incorporating information across multiple potentially heterogeneous data sources
Angela Yaqian Zhu, Dooti Roy, Zheng Zhu, et al.
Statistics in Medicine
|
April 30, 2023
Bayesian borrowing for basket trials with longitudinal outcomes
Lou E Whitehead, Oliver Sailer, Miles D Witham, et al.
International Journal of Pediatric Obesity : IJPO : an Official Journal of the International Association for the Study of Obesity
|
August 7, 2009
Sensory preferences and discrimination ability of children before and after an obesity intervention
Ute Alexy, Anke Schaefer, Oliver Sailer, et al.
Pharmaceutical Statistics
|
October 3, 2023
Duration of and time to response in oncology clinical trials from the perspective of the estimand framework
Hans-Jochen Weber, Stephen Corson, Jiang Li, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Pharmaceutical Statistics
|
February 24, 2017
Probability of success for phase III after exploratory biomarker analysis in phase II
Heiko Götte, Marietta Kirchner, Martin Oliver Sailer
CPT: Pharmacometrics & Systems Pharmacology
|
August 30, 2023
Pharmacometrics enhanced Bayesian borrowing approach to improve clinical trial efficiency: Case of empagliflozin in type 2 diabetes
Lucie Fayette, Martin Oliver Sailer, Alejandro Perez-Pitarch
Pharmaceutical Statistics
|
May 20, 2021
The detailed clinical objectives approach to designing clinical trials and choosing estimands
James Bell, Alan Hamilton, Oliver Sailer, et al.
Statistics in Medicine
|
April 25, 2017
Simulation-based adjustment after exploratory biomarker subgroup selection in phase II
Heiko Götte, Marietta Kirchner, Martin Oliver Sailer, et al.
Statistical Methods in Medical Research
|
April 16, 2026
Bayesian sample size determination using robust commensurate priors with interpretable discrepancy weights
Lou E Whitehead, James Ms Wason, Oliver Sailer, et al.
Biometrics
|
April 29, 2016
On confidence intervals for the hazard ratio in randomized clinical trials
Dan-Yu Lin, Luyan Dai, Gang Cheng, et al.
Journal of Biopharmaceutical Statistics
|
March 8, 2023
Propensity score stratified MAP prior and posterior inference for incorporating information across multiple potentially heterogeneous data sources
Angela Yaqian Zhu, Dooti Roy, Zheng Zhu, et al.
Statistics in Medicine
|
April 30, 2023
Bayesian borrowing for basket trials with longitudinal outcomes
Lou E Whitehead, Oliver Sailer, Miles D Witham, et al.
International Journal of Pediatric Obesity : IJPO : an Official Journal of the International Association for the Study of Obesity
|
August 7, 2009
Sensory preferences and discrimination ability of children before and after an obesity intervention
Ute Alexy, Anke Schaefer, Oliver Sailer, et al.
Pharmaceutical Statistics
|
October 3, 2023
Duration of and time to response in oncology clinical trials from the perspective of the estimand framework
Hans-Jochen Weber, Stephen Corson, Jiang Li, et al.
Page
of 2